Back to top

Is Cigna (CI) Stock Outpacing Its Finance Peers This Year?

Read MoreHide Full Article

Investors focused on the Finance space have likely heard of Cigna (CI - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Finance sector should help us answer this question.

Cigna is a member of our Finance group, which includes 853 different companies and currently sits at #9 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. CI is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past three months, the Zacks Consensus Estimate for CI's full-year earnings has moved 2.33% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Our latest available data shows that CI has returned about 6.49% since the start of the calendar year. In comparison, Finance companies have returned an average of -5.81%. This means that Cigna is performing better than its sector in terms of year-to-date returns.

To break things down more, CI belongs to the Insurance - Multi line industry, a group that includes 26 individual companies and currently sits at #98 in the Zacks Industry Rank. Stocks in this group have lost about 11.86% so far this year, so CI is performing better this group in terms of year-to-date returns.

Going forward, investors interested in Finance stocks should continue to pay close attention to CI as it looks to continue its solid performance.




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Cigna Corporation (CI) - free report >>

More from Zacks Tale of the Tape

You May Like

Published in